Xilio Therapeutics Inc (XLO) PT Lowered to $25 at Guggenheim
Tweet
Share
E-mailGet Alerts XLO Hot Sheet
Price: $9.17 +1.78%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Guggenheim analyst Michael W. Schmidt lowered the price target on Xilio Therapeutics Inc (NASDAQ: XLO) to $25.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
